Low Residue Diet During 3 Days vs 1 Day Prior Colonoscopy

February 10, 2020 updated by: Salvador Machlab, Hospital Parc Taulí, Sabadell

Low Residue Diet 3 Days Versus 1 Day as Preparation for Colonoscopy: a Randomized Controlled Trial

Colonoscopy is the gold-standard for the evaluation of the colorectal mucosa. Colonoscopy quality indicators are the adenoma detection rate, the rate of cecal intubation and the bowel preparation.

The role of diet in preparing for colonoscopy is not fully established. Currently there is not enough evidence available to choice between 3 days of low residue diet versus 1 day.

The research hypothesis is that the low residue diet offers a non-inferior bowel preparation and an improved tolerance.

Study Overview

Study Type

Interventional

Enrollment (Actual)

858

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Barcelona
      • Sabadell, Barcelona, Spain, 08208
        • Hospital Parc Tauli

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

50 years to 69 years (ADULT, OLDER_ADULT)

Accepts Healthy Volunteers

Yes

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • Participants in the colorectal cancer screening program that give consent

Exclusion Criteria:

  • Contraindication for colonoscopy

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: DIAGNOSTIC
  • Allocation: RANDOMIZED
  • Interventional Model: PARALLEL
  • Masking: TRIPLE

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
EXPERIMENTAL: 1 day low residue diet
Patients are instructed to complete a low residue diet exclusively one day prior the colonoscopy.
Patients are interviewed and instructed by a nurse prior the colonoscopy. They receive oral and written dietary information. In case of morbidity associated with bad preparation they are given bisacodyl the night before the colonoscopy.
Other Names:
  • low fiber diet
ACTIVE_COMPARATOR: 3 days low residue diet
Patients are instructed to complete a low residue diet three days prior the colonoscopy.
Patients are interviewed and instructed by a nurse prior the colonoscopy. They receive oral and written dietary information. In case of morbidity associated with bad preparation they are given bisacodyl the night before the colonoscopy.
Other Names:
  • low fiber diet

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Bowel preparation
Time Frame: During the colonoscopy
Measured with the Boston Bowel Preparation Scale from 0 until 9. 9 represents an excellent preparation.
During the colonoscopy

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Diet tolerance
Time Frame: It is reported before entering the endoscopy room. Regarding the 3 or 1 days on low fiber diet depending on which study group is the participant.
Using Likert scale. From 1 to 5, lower is better tolerance.
It is reported before entering the endoscopy room. Regarding the 3 or 1 days on low fiber diet depending on which study group is the participant.
Preparation tolerance
Time Frame: It is reported before entering the endoscopy room. Regarding the 3 or 1 day on bowel preparation depending on which study group is the participant.
Using Likert scale. From 1 to 5, lower is better tolerance.
It is reported before entering the endoscopy room. Regarding the 3 or 1 day on bowel preparation depending on which study group is the participant.
Adenoma detection rate
Time Frame: up to 2 weeks after colonoscopy depending on pathology department workload.
Proportion of colonoscopies with detection of colorectal cancer or adenoma excluding distal hyperplastic
up to 2 weeks after colonoscopy depending on pathology department workload.
Endoscopic diagnosis
Time Frame: It is assessed during the colonoscopy and will be reported the same day.
Final endoscopic diagnosis. For example; normal, diverticulosis, polyps, colorectal cancer, etc.
It is assessed during the colonoscopy and will be reported the same day.
Cecum intubation rate
Time Frame: It will be calculated through study completion, approximately 1 year, for all the study period using all participants having the colonoscopy done
Cecum intubation will be assessed during each colonoscopy if the endoscope reaches the cecum.
It will be calculated through study completion, approximately 1 year, for all the study period using all participants having the colonoscopy done
Intubation time
Time Frame: it is assessed from the start of the colonoscopy until cecum is reached (1 day)
time lapse from the start of the exploration until cecum is reached.
it is assessed from the start of the colonoscopy until cecum is reached (1 day)
Withdrawal time
Time Frame: it is assessed from at the beginning of the withdrawal of the colonoscope until the colonoscopy is finished. (procedure)
Time lapse between cecum withdrawal the end of the exploration.
it is assessed from at the beginning of the withdrawal of the colonoscope until the colonoscopy is finished. (procedure)

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Study Director: Eva Martínez, PhD, Corporacio Sanitaria Parc Tauli
  • Principal Investigator: Salvador Machlab, MD, Corporacio Sanitaria Parc Tauli
  • Study Director: Rafel Campo, PhD, Corporacio Sanitaria Parc Tauli

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (ACTUAL)

December 6, 2018

Primary Completion (ACTUAL)

November 10, 2019

Study Completion (ACTUAL)

January 20, 2020

Study Registration Dates

First Submitted

November 10, 2018

First Submitted That Met QC Criteria

December 3, 2018

First Posted (ACTUAL)

December 4, 2018

Study Record Updates

Last Update Posted (ACTUAL)

February 12, 2020

Last Update Submitted That Met QC Criteria

February 10, 2020

Last Verified

February 1, 2020

More Information

Terms related to this study

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Colorectal Neoplasms

Clinical Trials on 1 day low residue diet

3
Subscribe